China Real Estate: Continued Fund Rotation Drives New Lows

144 active MSCI China equity funds, AUM $40bn China Real Estate: Continued Fund Rotation Drives New Lows Summary Record Low Allocations: Real Estate holdings in active China equity funds have plummeted to a new low of 2.51%, with only 76.4% of funds maintaining any position. Concentrated Holdings: The number of Real Estate companies held has dropped to 42, with the …

Continue Reading

Active Asia Ex-Japan Funds: Top-Down Country Insights

99 Asia Ex-Japan active equity funds, AUM $55bn Active Asia Ex-Japan Funds: Top-Down Country Insights Summary South Korean Pivot:  Asia Ex-Japan investors move to overweight South Korea for the first time in our history, SK Hynix and Kia Corp among the beneficiaries.    India Fatigue: Despite India’s outperformance and rising fund weights, managers show caution, with nearly 2/3rds of funds …

Continue Reading

New Dashboard Release

355 emerging market Funds, AUM $410bn New Dashboard Release This video marks the launch of three new fund positioning dashboards, now available in our positioning dashboards suite. Watch the demo video opposite, or click on the link to go directly to the dashboards. Country/Sector DashboardGain immediate insights into country, sector, country/sector, and stock positioning. Customize your view with various ownership …

Continue Reading

Active Global Funds: Top-Down Country Insights

333 Global funds, AUM $1.1tr Active Global funds: Top-Down Country Insights   Summary Americas Dominance: The United States remains the top allocation and largest country underweight.  Value funds increase underweight in the USA but Growth funds reduce.  Argentina rises at Brazil’s expense, with MercadoLibre gaining popularity. EMEA Conviction Overweight: The UK, France, and the Netherlands maintain near-record overweights. France sees …

Continue Reading

Active GEM Funds: Top-Down Country Insights

355 emerging market Funds, AUM $410bn Active GEM Funds: Top-Down Country Insights Summary In this Top-Down Country report, we analyse regional and country allocations among the 355 equity funds in our analysis. Highlights from the report: EMEA Momentum: EMEA is experiencing positive momentum across multiple countries, with record investments in the MENA region, strong momentum in Greece, Turkey reversing long-term …

Continue Reading

Active UK Small/Midcap Funds: Extreme Stocks

104 active UK Small/Midcap equity funds, AUM $37bn Active UK Small/Midcap Funds: Extreme Stocks Summary In this report, we identify seven stocks that are currently positioned at the extreme ends of their historical position ranges, or have experienced significant shifts in fund ownership in recent months. Extreme Stocks in Focus: -Diversified Energy Company PLC-Team17 Group PLC-Rentokil Initial plc-St.James’s Place Plc-NCC …

Continue Reading

Active GEM Funds: Extreme Stocks

351 Global EM active equity funds, AUM $420bn Active GEM Funds: Extreme Stocks Summary In this report, we identify eight stocks that are currently positioned at the extreme ends of their historical position ranges, or have experienced significant shifts in fund ownership in recent months. Extreme Stocks in Focus: – HDFC Bank Limited – Delta Electronics, Inc. – POSCO Holdings …

Continue Reading

China Funds: Performance & Attribution Review, Q1 2024

143 MSCI China Equity funds, AUM $39bn MSCI China Funds: Performance & Attribution Review, Q1 2024   Summary • Tough start to 2024, but Active Funds match Benchmark: Average returns of -2.53% lag the iShares MSCI China ETF by -0.05%, with 47.8% of funds outperforming. • Value beats Growth: Value beats Growth on average, but best performers are from the …

Continue Reading

UK Funds: Performance & Attribution Review, Q1 2024

268 UK Equity funds, AUM $192bn UK Funds: Performance & Attribution Review, Q1 2024   Summary • UK Funds Stick to Benchmark in Q1: Average UK fund returns of 2.74% sit marginally behind SPDRs MSCI ACWI ETF by -0.33%, with 47.6% of funds outperforming. • Value Trumps Growth: Value and GARP funds beat their Growth peers, with 20% separating the …

Continue Reading

Global Funds: Performance & Attribution Review, Q1 2024

338 Global funds, AUM $1.1tr Global Funds: Performance & Attribution Review, Q1 2024   Summary Strong start to 2024, but majority underperform: Average returns of 7.6% lags the SPDRs MSCI ACWI ETF by -0.33%, with 44% of funds outperforming. Growth beats Value: Aggressive Growth funds the star performers with 8.3% returns on average. Value funds underperform benchmark with 6.9% Q1 …

Continue Reading

Terms and Conditions

Investor Positioning Report — Copley Fund Research Ltd  ·  Last updated: July 2026  ·  Registered in England and Wales

1. Who we are

Copley Fund Research Ltd provides proprietary institutional fund intelligence to listed companies and investor relations professionals. These terms govern every purchase of an Investor Positioning Report. By completing a purchase you confirm you have read, understood, and agreed to these terms in full.

2. What you are purchasing

The Investor Positioning Report is a bespoke PDF report mapping the institutional fund universe around your stock. It covers current investors, past investors, competitor investors, and white space investors. Every report is built from scratch for the specific company ordered and is not a standardised or templated product.

3. Delivery and process

Following payment or invoice issuance, Copley Fund Research will contact you within one working day to agree your competitor set. Production begins once the competitor set is confirmed in writing. The completed report will be released to you within 48 hours of production starting, provided payment has been received in full; where payment is outstanding, the report will be withheld until payment clears. If the requested company falls outside our covered fund universes, or a competitor set cannot be agreed, Copley Fund Research will issue a full refund or cancel the outstanding invoice.

4. Competitor set agreement

The competitor set is agreed with you in writing prior to production, and the report is built to that agreed specification. Requests to amend the competitor set after delivery, based on a change of preference rather than an error, may be treated as a new order.

5. Refund policy

Because each report is produced individually for your company, orders are non-refundable once production has begun, except as set out in clauses 3 and 5a below. By purchasing, you agree not to dispute the charge with your card provider on the basis that the service was not as described, provided the report has been delivered to the agreed specification or corrected under clause 5a.

5a. Quality remedy

If a delivered report contains a material error caused by Copley Fund Research — for example, an incorrect company analysed, a competitor omitted from the agreed set, or content missing from the specification in clause 2 — Copley Fund Research will correct and redeliver the report at no additional charge, within a reasonable timeframe. This is your sole remedy for such errors.

6. Data and accuracy

All fund positioning data in the report reflects holdings as disclosed at the most recently available reporting date at the time of compilation. The timing of fund holdings disclosures is determined by regulatory requirements applicable to each fund and is outside the control of Copley Fund Research Ltd. This data may not reflect current fund positions. Copley Fund Research takes reasonable care to ensure accuracy but makes no warranty, express or implied, as to the completeness or current accuracy of the underlying data — though this does not affect the quality remedy in clause 5a for errors in how that data was analysed or presented. Past fund positioning is not indicative of future fund behaviour or investment decisions.

7. Not investment advice

The Investor Positioning Report is produced for investor relations intelligence purposes only. It does not constitute investment advice, financial advice, or a recommendation to buy, hold, or sell any security. The data reflects historical fund positioning and must not be relied upon as a prediction of future fund behaviour or investment decisions. Copley Fund Research Ltd is not authorised or regulated by the Financial Conduct Authority for the provision of investment advice.

8. Permitted use and confidentiality

The report is licensed for internal use by the purchasing organisation only. You may share it with employees and directors of your organisation. You may not: reproduce, redistribute, publish, or resell the report or any part of it; share it with any third party outside your organisation without prior written consent; use the fund or portfolio manager names contained in the report to approach those individuals on behalf of Copley Fund Research or in a manner that could damage Copley Fund Research's relationships with those funds; or use the data for any purpose other than your own investor relations strategy. The data, analysis, and methodology contained in the report are the intellectual property of Copley